Navigation Links
HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy

According to researchers, Breast Cancer Patients with HER-2 Positive tumor who do not respond well to Herceptin alone could benefit// with a combination of drug Herceptin and one or more P13K-inhibiting agents.

The research team at the University of Texas M.D. Anderson Cancer Center in Houston is due to conduct anther trial, after having successfully tested it on mice. The second stage of the trial, will involve severe cancer cases where the disease has advanced in spite of Herceptin Treatment in Her2 positive patients.

Study author Dr. Dihua Yu, a professor in the department of surgical oncology said 'More than half of patients with HER2-positive tumors don't respond to Herceptin as a single agent, and our research has shown us why that is and what might be done to help these patients. If this drug cocktail shows benefit, we hope to be able to identify those patients who won't respond to Herceptin before they start the treatment, and offer them a new and beneficial drug combination. Patients who don't respond to Herceptin have worrisome outcomes, so we hope this strategy will help them.'

There is ample indication, supported by successful outcomes of previous research, which has provided the impetus to a combination treatment for aggressive breast cancers.


'"/>




Page: 1

Related medicine news :

1. When Her Lot is maligned by HER-2, Staying Abreast is Imperative
2. The Positive Effects Of A Healthy Lifestyle
3. The Positive Effects Of A Healthy Lifestyle
4. Positive Thinking
5. Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical
6. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
7. HIV Positive People Touching 60,000 In UK
8. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes
9. HIV Positive Men in Singapore Exposed
10. Positive Emotions lead To Life Longevity
11. New Fund Launched To Help HIV Positive Women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
Breaking Medicine Technology: